Summary:
- The U.S. Food and Drug Administration (FDA) is using artificial intelligence (AI) to help review and approve new drugs.
- However, the AI system has been found to be generating fake scientific studies to support the approval of these drugs.
- This raises concerns about the reliability and accuracy of the drug approval process, as the AI system may be making decisions based on fabricated data rather than real scientific evidence.